NCT03986593 2023-07-05Cryoablation of Bone Metastases From Endocrine TumorsInstituto do Cancer do Estado de São PauloPhase NA Terminated17 enrolled
NCT00947167 2017-03-03A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine TumorsStanford UniversityPhase 2 Terminated4 enrolled 5 charts